Federal Register / Vol. 71, No. 163 / Wednesday, August 23, 2006 / Notices 49461 

ADDRESSES: Mail applications for the 

Senior Risk Reduction Demonstration 

to—Centers for Medicare & Medicaid 

Services, 7500 Security Boulevard, 

Baltimore, Maryland 21244–1850. 

Medicare Demonstrations Program 

Group, Mail stop S3–02–01, Attention: 

Pauline Lapin. 

FOR FURTHER INFORMATION CONTACT: 

Pauline Lapin, (410) 786–6883 or 

Sidney Trieger, (410) 786–6613. 

SUPPLEMENTARY INFORMATION:

I. Background 

The aging of the population, the 

prevalence of chronic disease, and the 

rapidly rising cost of health care in the 

United States provides a sense of 

urgency and immediacy for finding 

innovative solutions that would 

improve the health and well-being of 

seniors and prevent or delay debilitating 

and costly disease onset. 

Recent research suggests that wellstructured risk reduction programs can 

achieve significant improvements in a 

population’s health risk profile. 

Successful programs are founded on 

solid behavior change theory, use 

tailored interventions, are personalized 

and sufficiently intensive, and are 

delivered with adequate social supports. 

In 2001, CMS commissioned RAND, and 

RAND prepared, a report on risk 

reduction programs entitled, ‘‘The 

Evidence Report and Evidence Based 

Recommendations: Health Risk 

Appraisals and Medicare.’’ This report 

concluded that effective risk reduction 

programs, beginning with the 

administration of a Health Risk 

Appraisal (HRA) and including 

evidence-based and tailored behavior 

change through follow-up interventions, 

exert a beneficial effect on behavioral, 

physiological, and general health status 

outcomes. Other supportive studies 

have shown that multicomponent health 

promotion programs that engage 

participants in self-care activities and 

increase their involvement in health 

care decision-making can achieve longterm behavior changes and health risk 

reductions in large populations. 

Also, evidence is mounting that 

successful risk reduction programs may 

produce a positive return on 

investment. Based on this evidence, the 

RAND report concluded that health 

promotion and disease prevention 

programs using HRAs and ongoing 

tailored interventions may be cost 

beneficial. Experts agree that the 

approach used in risk reduction 

programs is promising for Medicare 

beneficiaries and should be tested in a 

demonstration project. 

II. Provisions of the Notice 

The purpose of the notice is to inform 

interested parties of an opportunity to 

implement a risk reduction/health 

management program as part of the 

Medicare Senior Risk Reduction 

Demonstration. The goal of this 

demonstration project is to determine 

whether risk reduction programs (also 

referred to as health promotion, health 

management, demand management, and 

disease prevention programs) that have 

been developed and tested in the private 

sector can also be tailored to, and work 

well with, Medicare beneficiaries to 

improve their health and reduce 

avoidable health care utilization. The 

specific aims are to—

• Determine whether a senior risk 

reduction service provided by Medicare 

will—

—Be viewed positively by beneficiaries. 

—Be accepted by beneficiaries. 

—Achieve high participation rates. 

—Reduce health risk factors, improve 

health behaviors, improve 

functioning, and prevent disability. 

• Produce cost savings for the 

Medicare program. 

Applicants must be willing to accept 

a 10 percent withhold of their fee each 

year, and as much as a 15 percent 

withhold over the course of the 

demonstration should Medicare 

expenditures for the intervention group 

exceed those of the control group by 

more than 5 percent after the first 18 

months of the demonstration. 

We intend to use a competitive 

application process to select up to five 

existing health promotion, disease 

prevention, health management, or risk 

reduction organizations to participate in 

the demonstration project. Interested 

parties can obtain complete solicitation 

and supporting information on the CMS 

Web site at http://www.cms.hhs.gov/ 

DemoProjectsEvalRpts/downloads/ 

Senior_Risk_Reduction_Solicitation.pdf. 

We anticipate that we will make final 

award decisions by April 1, 2007, and 

that project implementation activities 

would begin July 1, 2007. 

III. Collection of Information 

Requirements 

The document does impose 

information collection and 

recordkeeping requirements. However, 

since we believe there are less than 10 

potential respondents, of which CMS 

will be selecting 5 applicants to 

participate in the demonstration, this 

collection is exempt from the PRA as 

stipulated under 5 CFR 1320.3(c)(4). 

Authority: Section 402(a)(1)(B) of the 

Social Security Amendments of 1967, Pub. L. 

No. 90–248, as amended, 42 U.S.C. 1395b–

1(a)(1)(B) and (a)(2). 

(Catalog of Federal Domestic Assistance No. 

93.773 Medicare—Hospital Insurance 

Program; and No. 93.774, Medicare—

Supplementary Medical Insurance Program). 

Dated: July 20, 2006. 

Mark B. McClellan, 

Administrator, Centers for Medicaid & 

Medicare Services. 

[FR Doc. 06–7120 Filed 8–21–06; 4:00 pm] 

BILLING CODE 4120–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Fogarty International Center Advisory 

Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in section 

552b(c)(9)(B), Title 5 U.S.C., as 

amended. The grant applications and/or 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and/or contract proposals, the 

disclosure of which could constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: September 11–12, 2006. 

Closed: September 11, 2006, 1 p.m. to 5 

p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Open: September 12, 2006, 8:30 a.m. to 5 

p.m. 

Agenda: Preliminary Discussions of the 

Strategic Planning for the Fogarty 

International Center. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 


sroberts on PROD1PC70 with NOTICES
49462 Federal Register / Vol. 71, No. 163 / Wednesday, August 23, 2006 / Notices 

Jean L. Flagg-Newton, PhD, Special 

Assistant to the Director, FIC, Fogarty 

International Center, National Institutes of 

Health, 9000 Rockville Pike, Building 31, 

Room B2C29, Bethesda, MD 20892, (301) 

496–2968; flaggnej@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of the 

visitor. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nih.gov/fic/about/advisory.html, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 

Awards Program, National Institutes of 

Health, HHS). 

Dated: August 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7082 Filed 8–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Commitee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: September 28, 2006. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: (1) Approval Minutes of June 8, 

2006 Teleconference; (2) Introduce new 

DCLG Members; (3) Report of Summit 

Working Group to the DCLG; (4) Report of 

Agenda Working Group; (5) Public Comment; 

(6) Action Items and Conclusion. 

Place: National Institutes of Health, 

National Cancer Institute, 6116 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Barbara Guest, Executive 

Secretary, Office of Liaison Activities, 

National Cancer Institute, National Institutes 

of Health, 6116 Executive Blvd, Room 2202, 

Bethesda, MD 20892–8324, 301–496–0307, 

guestb@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/dclg/dclg.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 16, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7081 Filed 8–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

J—Population and Patient-Oriented Training, 

Population and Patient-Oriented Training. 

Date: October 24–25, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Radisson Hotel Old Town 

Alexandria, 901 North Fairfax Street, 

Alexandria, VA 22314. 

Contact Person: Ilda M. McKenna, PhD, 

Scientific Review Administrator, Research 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8111, Bethesda, MD 20892, 301–496–7481, 

mckennai@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower, 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7086 Filed 8–22–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel 

Mentored Patient-Oriented Research Career 

Development Award. 

Date: September 5, 2006. 

Time: 2 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 


sroberts on PROD1PC70 with NOTICES